BUSINESS● LOWJun 30 · Jun 30, 2026, 1:21 PM
Nurix Therapeutics, Inc. (NRIX) Price Target Raised to $33 on Roche Partnership Value
Yahoo Finance
The price target for Nurix Therapeutics, Inc. (NRIX) has been raised due to the perceived value of its partnership with Roche. This indicates a positive financial outlook for the company based on its collaboration.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESS5m agoAt a glance: stocks gapping down premarketSeeking Alpha TechBUSINESS6m agoProcter & Gamble in charts: FQ1 saw double-digit Q/Q growth across nearly all major segmentsSeeking Alpha Tech